Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Rita Humeniuk, PhD

Gilead Sciences, Inc.

Disclosure(s): Gilead Sciences, Inc.: Former Employee, Stocks/Bonds (Public Company)

Poster(s):

(P-2026) Obeldesivir for the Treatment of COVID-19 in People with Risk Factors for Progression to Severe Disease: the BIRCH Study

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
(P-2036) Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT